目录产品 » 抗体产品 » 一抗 » SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric
Manual
SDS
COAs
Z03483) .
Coating antigen: recombinant SARS-CoV-2 Spike Protein S1 RBD, 0.5 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
EC50= 0.088 µg/ml. " data-src="/product/documents/down?doc_name=ELISA1.jpg&file=scm_files/productFile_notes/2020/03/27/08d04a4da7415cbeb6f0807195fc10cd.jpg">
Z03497).
Coating antigen: recombinant SARS-CoV-2 NP&RBD, 0.5 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
EC50= 0.059 µg/ml. " data-src="/product/documents/down?doc_name=ELISA 2.jpg&file=scm_files/productFile_notes/2020/04/20/9f902eaada79e629098d353fd091d1ce.jpg">

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
￥2800
A02038

产品概述
Specificity The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain.
Host Species Human
Immunogen Recombinant SARS-CoV-2 RBD Protein
Conjugate Unconjugated
返回

应用指导
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.1-10 µg/ml
返回

产品属性
Form Liquid
Storage Buffer Supplied in PBS, pH 7.4, containing 0.02% sodium azide.
Concentration 1 mg/ml
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. Avoid repeated freezing and thawing cycles.
Purification Protein A affinity column
Isotype Recombinant human IgG1
Clonality Monoclonal
Clone ID HC2001
Note GenScript can customize this product per customer's request including product size, buffer components, etc.
返回

图例
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

»

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with recombinant SARS-CoV-2 Spike Protein S1 RBD(GenScript, Z03483) .
Coating antigen: recombinant SARS-CoV-2 Spike Protein S1 RBD, 0.5 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
EC50= 0.088 µg/ml. »

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with recombinant SARS-CoV-2 NP&RBD(GenScript, Z03497).
Coating antigen: recombinant SARS-CoV-2 NP&RBD, 0.5 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 25 µg/ml.
EC50= 0.059 µg/ml. »

SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric

ELISA binding of SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) with SARS-CoV-2 Spike protein (RBD, His Tag, CHO-expressed) (GenScript, Z03514) .
Coating antigen: SARS-CoV-2 Spike protein (RBD, His Tag, CHO-expressed) (GenScript, Z03514) , 1 µg/ml.
SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric (GenScript, A02038) dilution start from 1 µg/ml.
EC50= 10.3 ng/ml. »

<
>

技术背景
Target Background SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells. SARS-CoV-2 Spike S1 Antibody (HC2001), Human Chimeric is produced from cell culture in vitro under conditions free from animal-derived components.
Synonyms 2019-nCoV Spike S1 Antibody (HC2001), SARS-CoV-2 S1 RBD Antibody
返回

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.


相关文献
Jeong Seok Yu, et al. Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver disease. Clin Transl Med. (2021-12)
Muhammad Ali Ehsan, et al. Screen-Printed Graphene/Carbon Electrodes on Paper Substrates as Impedance Sensors for Detection of Coronavirus in Nasopharyngeal Fluid Samples. Diagnostics (Basel). (2021-06)
Carleen Klumpp-Thomas, et al. Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling. Nat Commun. (2021-01)
Hansen CB, et al. SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals. Journal of immunology (Baltimore, Md. : 1950). (2021-01)